Navigation Links
Common Painkillers May Blunt Antidepressants
Date:4/25/2011

By Steven Reinberg
HealthDay Reporter

MONDAY, April 25 (HealthDay News) -- Common over-the-counter painkillers such as ibuprofen, aspirin and naproxen may reduce the effectiveness of antidepressants called selective serotonin reuptake inhibitors, or SSRIs, according to a mouse and human study from The Rockefeller University in New York City.

SSRIs -- which are the most common antidepressants and are used by millions of people -- include such popular drugs as Lexapro, Prozac, Paxil and Zoloft. The potential interaction between these drugs and the painkillers known as nonsteroidal anti-inflammatory drugs (NSAIDs) may be a reason that some people don't respond to SSRIs, the researchers report.

"In one study, we found that anyone who reported use of an anti-inflammatory or analgesic agent had a much poorer treatment outcome compared to people who didn't report any use of NSAIDs," said study lead author Jennifer Warner-Schmidt.

One of the open questions is what dose is needed over what time period to produce this effect, said Warner-Schmidt, a research associate in the university's laboratory of molecular and cellular neuroscience. "Until a double-blind real clinical trial is done, we can't say what the dose is [or] what the time course is," she said.

"We may only be looking at people who are taking NSAIDs over a long period of time, but it's not clear," she explained.

In addition, why NSAIDs blunt the effect of SSRIs isn't known, Warner-Schmidt said, adding that "we have some speculative hypotheses we will be exploring in further studies."

Even with these caveats, Warner-Schmidt characterizes the effect of the interaction between these drugs as strong.

"If people out there are having trouble with SSRI efficacy and they happen to be taking anti-inflammatory drugs, they may want to speak with their clinician to evaluate whether they need to continue on the anti-inflammatory drugs, and if so, they may consider changing their antidepressant to a different class of antidepressant," Warner-Schmidt said.

The report was published in the April 25 online edition of the Proceedings of the National Academy of Sciences.

For their study, the researchers gave mice SSRIs with and without NSAIDs. By looking at how the mice behaved in tasks sensitive to antidepressants, the researchers found those behaviors inhibited in the mice given NSAIDs.

Warner-Schmidt's team confirmed these findings using data from a previous human study. In that trial, people taking NSAIDs were less likely to have their depressive symptoms relieved by SSRIs than those not taking NSAIDs.

In fact, 54 percent those not taking these anti-inflammatory painkillers said SSRIs relieved their depressive symptoms, compared with 40 percent of those taking both NSAIDs and SSRIs, Warner-Schmidt said.

In addition to their implications for treating depression, these findings may also be important to Alzheimer's patients, according to lead researcher Nobel Laureate Paul Greengard, the Vincent Astor Professor of the Laboratory of Molecular and Cellular Neuroscience at The Rockefeller University.

"Many elderly individuals suffering from Alzheimer's disease also have arthritic or related diseases and as a consequence are taking both antidepressant and anti-inflammatory medications. Our results suggest that physicians should carefully balance the advantages and disadvantages of continuing anti-inflammatory therapy in patients being treated with antidepressant medications," he said in university news release.

"This is an important observation that needs to be followed up," said Dr. Charles Nemeroff, the Leonard M. Miller Professor and chairman of the psychiatry and behavioral sciences department at the University of Miami Miller School of Medicine.

"If it is possible that drugs that treat pain in any way antagonize the effects of antidepressants, it's really important to know because of the widespread use of both agents," Nemeroff added, noting that depressed patients with chronic pain are difficult to treat.

"The belief has always been that they are difficult to treat because chronic pain wears people down and drives them into depression, but this is a different wrinkle. This would suggest it may be that medications being used to treat their chronic pain may, in fact, be obviating the effects of antidepressants," he said.

While it is too early to draw definitive clinical conclusions from this study, Nemeroff thinks doctors should ask their patients if they are taking NSAIDs when prescribing SSRIs.

"If you treat [patients] with an SSRI and they don't respond, maybe we ought to ask them if they are taking high doses of NSAIDs," Nemeroff said. "If they are, we might think about finding another way to treat their pain or inflammation," he said.

More information

For more information on depression, visit the U.S. National Institute of Mental Health.

SOURCES: Jennifer Warner-Schmidt, Ph.D., research associate, The Rockefeller University, New York City; Charles Nemeroff, M.D., Ph.D., Leonard M. Miller Professor and chairman of the department of psychiatry and behavioral sciences, University of Miami Miller School of Medicine; April 25, 2011, Proceedings of the National Academy of Sciences, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Prenatal exposure to common insecticide linked to decreases in cognitive functioning at age 7
2. Depression Common After Brain Injury
3. Treatment-resistant epilepsy common in idiopathic autism
4. Can Common Virus, Lack of Sunlight Boost MS Risk?
5. Hookah Use Common Among College Students, Survey Finds
6. Report: Hospital Errors May Be Far More Common Than Suspected
7. Sudden Cardiac Death More Common in Young Athletes Than Thought
8. Common Birth Defect May Be Linked to Migraine With Aura
9. Study suggests a relationship between migraine headaches in children and a common heart defect
10. New mouse model explains common pediatric brain tumor
11. Popular drugs for common male health problems can affect their sexual health
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 Common Painkillers May Blunt Antidepressants  
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group ... Tournament held on June 20th at the Woodmont Country Club at 1201 Rockville ... an organization dedicated to helping service members that have been wounded in battle and ...
(Date:6/24/2016)... ... 24, 2016 , ... Finally, a bruise cream that really works. Originally ... incorporated into the post-surgical treatment plans of a variety of other procedures including, but ... very effective for bruising and causes a rapid resolution of bruising and inflammatory changes ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially launched its site, ... matching users with high quality water pipes within an ideal price range. The site ... was founded by two brothers, Nick and Mike Hunter, who use medical cannabis to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
Breaking Medicine Technology: